| Name | LFS-1107 |
|---|
| Description | LFS-1107 is a reversible CRM1 inhibitor (Kd: 12.5 pM). LFS-1107 can selectively eliminate extranodal natural killer/T cell lymphoma (ENKTL) cells and can be used for cancer research[1]. |
|---|---|
| Related Catalog | |
| Target |
COX-2 |
| References |
| Molecular Formula | C12H11N5OS2 |
|---|---|
| Molecular Weight | 305.38 |